IL22 and inflammatory bowel disease: Moreover, genes commonly associated with polymorphisms in IBD and colitis-associated cancer (CAC)—such as Card9—are required to control ILC3 activation and IL-22 production via regulation of the ILC3 activating cytokine IL-1β [113].